NCT04223622View on ClinicalTrials.gov

Effects of ASC Secretome on Human Osteochondral Explants

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

April 12, 2021

Primary Completion Date

July 17, 2024

Study Completion Date

July 17, 2024

Conditions
Osteoarthritis
Interventions
BIOLOGICAL

ASC secretome

The osteochondral explants isolated from arthroplasty patients will be induced to an OA phenotype and treated with ASC secretome (either complete conditioned medium or extracellular vesicles) in order to investigate its therapeutic potential.

Trial Locations (1)

20161

IRCCS Istituto Ortopedico Galeazzi, Milan

All Listed Sponsors
lead

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

OTHER